Get the Stockscreener App
5.92
2.47%
-0.15
Pre-market:
10.44
4.52
+76.35%
Enveric Biosciences Inc stock is traded at $5.92, with a volume of 343.38K.
It is down -2.47% in the last 24 hours and down -3.11% over the past month.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
See More
Previous Close:
$6.07
Open:
$6.04
24h Volume:
343.38K
Relative Volume:
4.33
Market Cap:
$3.53M
Revenue:
-
Net Income/Loss:
$-15.08M
P/E Ratio:
-0.9221
EPS:
-6.42
Net Cash Flow:
$-11.56M
1W Performance:
+1.72%
1M Performance:
-3.11%
6M Performance:
-62.05%
1Y Performance:
-90.84%
1-Day Range:
$5.75
$6.40
1-Week Range:
$5.6001
$6.991
52-Week Range:
$4.88
$96.30
Enveric Biosciences Inc Stock (ENVB) Company Profile
Name
Enveric Biosciences Inc
Sector
Industry
Phone
239-302-1707
Address
245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE
Compare ENVB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENVB
Enveric Biosciences Inc
|
5.92 | 3.62M | 0 | -15.08M | -11.56M | -6.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.01 | 112.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
692.58 | 73.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
415.21 | 56.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
889.41 | 55.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
194.17 | 41.92B | 447.02M | -1.18B | -906.14M | -6.1812 |
Enveric Biosciences Inc Stock (ENVB) Latest News
What Sparked Enveric Biosciences (ENVB) 74% Surge In After-Hours Trading? - Benzinga
Enveric Biosciences Receives Notice of Allowance for EVM301 Series of Drug Candidates - Investing News Network
Enveric Biosciences (ENVB) Gains Patent Approval for EVM301 Ment - GuruFocus
Enveric receives USPTO patent allowance for neuropsychiatric drug By Investing.com - Investing.com Canada
What analysts say about Enveric Biosciences Inc stockDividend Stability Analysis & Low Cost Portfolio Growth - earlytimes.in
Why Enveric Biosciences Inc. (SLZ) stock could outperform next yearEarnings Summary Report & High Yield Equity Trading Tips - Newser
Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 9th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2026” - Business Wire
A activity2025 Fundamental Recap & Weekly High Return Forecasts - Newser
Enveric Biosciences, Inc. (ENVB) Stock Price, News, Quote & History - Yahoo! Finance Canada
Will Enveric Biosciences Inc. (SLZ) stock top growth indexesBear Alert & Community Trade Idea Sharing - Newser
Enveric Biosciences (ENVB) Stock Analysis Report | Financials & Insights - Benzinga
How Enveric Biosciences Inc. (SLZ) stock stacks up against competitorsJuly 2025 Chart Watch & Precise Entry and Exit Recommendations - Newser
Enveric Biosciences (NASDAQ:ENVB) Shares Down 0.3% – Here’s What Happened - Defense World
Enveric Biosciences, Inc. (ENVB) -13.5% in After-hours: Stock Reacts After Recent Patent Allowance - Stocks Telegraph
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Is the Smart Money Moving Into Sathlokhar Synergys E C Global Limited Institutional Buying TrendsMerger & Acquisition Updates & Free Stock Index Interpretations - earlytimes.in
Enveric Biosciences Receives Fourth Notice of Allowance for EVM401 Series of Drug Candidates - BioSpace
Enveric Biosciences (ENVB) Advances with Patent Allowance for EV - GuruFocus
Enveric Biosciences receives patent allowance for neuropsychiatric drugs By Investing.com - Investing.com Canada
Enveric Biosciences Inc. (ENVB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Can Enveric Biosciences Inc. stock sustain institutional interestMarket Sentiment Report & Weekly Sector Rotation Insights - newser.com
Will Enveric Biosciences Inc. (SLZ) stock outperform global peersJuly 2025 Levels & Safe Capital Investment Plans - newser.com
Is Enveric Biosciences Inc. (SLZ) stock positioned for secular growthBull Run & Free Weekly Watchlist of Top Performers - newser.com
Is Enveric Biosciences Inc. (SLZ) stock considered safe havenMarket Movement Recap & Free Low Drawdown Momentum Trade Ideas - newser.com
How Enveric Biosciences Inc. stock performs in high volatility marketsJuly 2025 Movers & Reliable Volume Spike Alerts - newser.com
How risky is Enveric Biosciences Inc. (SLZ) stock compared to peersQuarterly Profit Report & Technical Entry and Exit Tips - newser.com
How to interpret RSI for Enveric Biosciences Inc. stock2025 Pullback Review & Advanced Technical Analysis Signals - newser.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Can Enveric Biosciences Inc. (SLZ) stock withstand sector downturnsJuly 2025 Final Week & Fast Gain Stock Tips - newser.com
Will Enveric Biosciences Inc. stock gain from government policiesWeekly Market Outlook & Verified Swing Trading Watchlists - newser.com
Will Enveric Biosciences Inc. stock split again soon2025 Earnings Surprises & High Accuracy Investment Entry Signals - newser.com
Is this a good reentry point in Enveric Biosciences Inc.2025 Dividend Review & Risk Controlled Daily Trade Plans - newser.com
Enveric Biosciences Inc Stock (ENVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):